Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Lorcaserin on Cannabis Withdrawal and Self-administration

NCT03253926 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03253926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 1/2
Overall status
Completed
Start date
September 5, 2017
Completion date
December 31, 2021
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use